CVR number 28130155
Industry 86.2200 Specialist medical practice activities

JORTO ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.8% 0.8% 0.7% 0.7% 1.6%  
Credit score (0-100)  94 92 93 95 73  
Credit rating  AA AA AA AA A  
Credit limit (kDKK)  809.3 1,050.3 1,170.4 1,298.3 20.7  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales  0 0 0 0 0  
Gross profit  1,029 845 1,142 1,181 1,244  
EBITDA  3,764 6,844 1,116 1,158 1,219  
EBIT  2,366 3,819 2,287 1,851 -459  
Pre-tax profit (PTP)  1,172.5 3,385.3 1,919.4 1,419.6 -891.7  
Net earnings  877.9 2,634.7 1,504.5 1,104.7 -698.4  
Pre-tax profit without non-rec. items  1,172 3,385 1,919 1,420 -892  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Tangible assets total  28,725 32,017 33,200 33,900 32,300  
Shareholders equity total  7,729 10,256 11,650 12,642 11,829  
Interest-bearing liabilities  17,046 16,702 16,395 16,022 15,692  
Balance sheet total (assets)  29,482 32,215 33,541 34,355 32,458  
Net Debt  16,362 16,544 16,140 15,692 15,590  
 
See the entire balance sheet

Volume 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,029 845 1,142 1,181 1,244  
Gross profit growth  -0.2% -17.9% 35.2% 3.4% 5.4%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  29,482 32,215 33,541 34,355 32,458  
Balance sheet change%  25.4% 9.3% 4.1% 2.4% -5.5%  
Added value  2,373.3 3,827.0 2,304.8 1,868.4 -458.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  5,959 3,285 1,165 700 -1,600  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 -1.0  

Profitability 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  229.9% 452.1% 200.2% 156.8% -36.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  8.9% 12.3% 7.1% 5.4% -1.4%  
ROI %  9.7% 13.9% 7.5% 5.6% -1.4%  
ROE %  15.5% 29.3% 13.7% 9.1% -5.7%  

Solidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Equity ratio %  26.5% 32.2% 35.1% 37.1% 36.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  434.7% 241.7% 1,445.6% 1,355.3% 1,279.4%  
Gearing %  220.5% 162.9% 140.7% 126.7% 132.7%  
Net interest  0 0 0 0 0  
Financing costs %  7.1% 2.5% 2.5% 2.6% 2.6%  

Liquidity 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Quick Ratio  0.2 0.1 0.4 0.5 0.1  
Current Ratio  0.2 0.0 0.3 0.3 0.1  
Cash and cash equivalent  684.0 157.9 255.1 329.8 102.3  

Capital use efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -3,167.2 -3,461.8 -735.7 -731.1 -1,023.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/9
2020
2020/9
2021
2021/9
2022
2022/9
2023
2023/9
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0